세계의 저체온 치료 시스템 시장 : 제품별(냉각 장치, 냉각 카테터, 쿨캡), 용도별(신경과, 순환기내과, 신생아 치료), 지역별 - 예측(-2028년)

Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) - Global Forecast to 2028

US $ 4,950 ￦ 7,084,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,517,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,664,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,312,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

조사 범위
조사 대상년도	2021년-2028년
기준년도	2022년
예측 기간	2023년-2028년
검토 단위	금액(100만 달러)
부문	제품별, 용도별, 최종사용자별
대상 지역	북미, 유럽, 아시아태평양 및 기타 지역

세계 저체온증 치료 시스템 시장 규모는 예측 기간 동안 CAGR 6.3%로 확대되어 2023년 2억 9,100만 달러에서 2028년 3억 9,600만 달러에 달할 것으로 예상됩니다.

시장 성장의 주요 원동력은 감염 및 만성 질환의 유병률 증가와 저침습적 냉각 방법의 사용 증가입니다. 그러나 대체 방법의 존재와 개발도상국에서의 낮은 인지도는 치료용 저체온 시스템 시장의 성장을 저해할 수 있습니다.

제품별로는 2022년 냉각 장치 부문이 시장을 주도했습니다. 이 부문의 큰 점유율은 사용 편의성, 사용 가능한 노동 집약적 인 장치가 적고 제어 장치를 통한 간단하고 효과적인 온도 조절 시스템의 존재에 기인합니다.

용도별로는 2022년 저체온 치료 시스템 시장에서 가장 높은 CAGR을 기록한 분야는 순환기 분야였습니다. 이 부문의 CAGR이 가장 높은 이유는 주로 심정지 환자 치료에 저체온 요법을 사용하는 것이 잠재적인 이점이 있기 때문입니다.

지역별로 보면, 북미는 예측 기간 동안 높은 시장 점유율을 차지할 것으로 예상됩니다. 기술적으로 진보된 치료용 저체온 시스템 제품의 존재와 의료기기 산업의 발전이 증가하면서 치료용 저체온 시스템 시장의 성장을 뒷받침하고 있습니다.

이 보고서는 세계 저체온증 치료 시스템 시장을 조사했으며, 제품별/용도별/최종사용자별/지역별 동향과 시장 진출기업 프로파일 등을 정리한 보고서입니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 밸류체인 분석
• 공급망 분석
• Porter의 Five Forces 분석
• 규제 분석
• 무역 분석
• 기술 분석
• 생태계 분석
• 특허 분석
• 2024년-2025년 주요 컨퍼런스 및 이벤트
• 가격 분석
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 주요 이해관계자와 구입 기준

제6장 저체온 치료 시스템 시장, 제품별

• 서론
• 냉각 장치
• 냉각 카테터
• 쿨캡

제7장 저체온 치료 시스템 시장, 용도별

• 서론
• 신경과
• 순환기과
• 신생아 케어
• 기타

제8장 저체온 치료 시스템 시장, 지역별

• 서론
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제9장 경쟁 구도

• 개요
• 주요 시장 진출기업이 채택한 전략
• 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스
• 스타트업/중소기업 평가 매트릭스
• 경쟁 시나리오와 동향

제10장 기업 개요

• 주요 시장 진출기업
  • ASAHI KASEI CORPORATION(ZOLL MEDICAL CORPORATION)
  • BECTON, DICKINSON AND COMPANY
  • GENTHERM INCORPORATED
  • STRYKER CORPORATION
  • BELMONT MEDICAL TECHNOLOGIES
  • INTERNATIONAL BIOMEDICAL LTD.
  • EM-MED
  • PHOENIX MEDICAL SYSTEMS
  • LIFE RECOVERY SYSTEMS
  • SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
  • MIRACRADLE(PLUSS ADVANCED TECHNOLOGIES PVT. LTD.)
• 기타 기업
  • TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
  • PFM MEDICAL HICO GMBH
  • VNG MEDICAL INNOVATION SYSTEM PVT. LTD.
  • ASPEN SYSTEMS
  • COOLTECH MEDICAL
  • GLOBAL HEALTHCARE SG
  • CRYOTHERMIC SYSTEMS INCORPORATED
  • PAXMAN COOLERS LTD.
  • DIGNITANA AB
  • WISHCAPS

제11장 부록

LSH

영문 목차

영문목차

Report Description

Scope of the Report
Years Considered for the Study	2021-2028
Base Year	2022
Forecast Period	2023-2028
Units Considered	Value (USD) Million
Segments	Product, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Rest of the World

The global therapeutic hypothermia systems market is projected to reach USD 396 million by 2028 from USD 291 million in 2023, at a CAGR of 6.3% during the forecast period. The growth of this market is majorly driven by the growing prevalence of infectious and chronic diseases and the rise in the use of minimally invasive cooling methods. However, the presence of alternative methods and less awareness in developing countries could restrain the growth of the therapeutic hypothermia systems market.

"Cooling devices segment accounted for the highest market share in the therapeutic hypothermia systems market, by product, during the forecast period."

Based on product, the therapeutic hypothermia systems market is classified into Cooling Catheters, Cooling devices and Cool Caps. The cooling devices segment dominated the market in 2022. The large share of the segment can be attributed to the ease of use, fewer labor-intensive devices available, and the presence of a simple and effective thermal regulating system with the control unit.

"Cardiology accounted for the highest CAGR during the forecast period."

Based on the application, the therapeutic hypothermia systems market is segmented into Neurology, Cardiology, Neonatal care, and other applications. The cardiology segment accounted for the highest CAGR of the therapeutic hypothermia systems market in 2022. The highest CAGR of this segment can be primarily attributed to the potential benefit of using hypothermia for treating cardiac arrest patients.

"The North America segment accounted for the highest market share in the therapeutic hypothermia systems market, by region, during the forecast period."

Based on the region, the global therapeutic hypothermia systems market is categorized into North America, Asia Pacific, Europe, and the Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced therapeutic hypothermia systems products and the increasing advancement in the medical device industries are supporting the growth of the therapeutic hypothermia systems market.

Breakdown of supply-side primary interviews by company type, designation, and region:

• By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
• By Designation: C-level (28%), Director-level (33%), and Others (39%)
• By Region: North America (21%), Europe (30%), Asia-Pacific (34%), and RoW (15%)

Prominent companies include ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), Stryker Corporation (US), Gentherm Incorporated (US), Belmont Medical Technologies (US), International Biomedical Ltd. (US), EM-MED (Poland), Phoenix Medical Systems (India), Life Recovery Systems (US), Shenzhen Comen Medical Instruments Co., Ltd. (China), MiraCradle (India), Terumo Cardiovascular Systems Corporation (US), pfm medical hico gmbh (Germany), VNG Medical Innovation System Pvt. Ltd. (India), Aspen Systems (US), CoolTech Medical (US), Global Healthcare SG (Singapore), Cryothermic Systems Incorporated (US), Paxman Coolers Ltd. (UK), Dignitana AB (Italy), and Wishcaps (US).

Research Coverage

This research report categorizes the therapeutic hypothermia systems market by product, application, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the therapeutic hypothermia systems market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the therapeutic hypothermia systems market. Competitive analysis of upcoming startups in the therapeutic hypothermia systems market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall therapeutic hypothermia systems market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the therapeutic hypothermia systems market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the therapeutic hypothermia systems market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the therapeutic hypothermia systems market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the therapeutic hypothermia systems market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), Stryker Corporation (US), among others in the therapeutic hypothermia systems market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • FIGURE 1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 STAKEHOLDERS
• 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 2 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 3 PRIMARY SOURCES
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Breakdown of primary interviews
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION
  • 2.2.2 APPROACH 2: NUMBER OF THERAPEUTIC HYPOTHERMIA SYSTEMS
  • TABLE 1 REVENUE ESTIMATION APPROACH BY CALCULATING MARKET SIZE OF THERAPEUTIC HYPOTHERMIA SYSTEMS
  • 2.2.3 APPROACH 3: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
  • 2.2.4 APPROACH 4: PRIMARY INTERVIEWS
  • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 8 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
• 2.4 MARKET SHARE ANALYSIS
• 2.5 MARKET ASSUMPTIONS
• 2.6 RISK ASSESSMENT
  • TABLE 2 RISK ASSESSMENT
• 2.7 RECESSION IMPACT ON THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET

3 EXECUTIVE SUMMARY

• FIGURE 10 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
• FIGURE 11 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET

4 PREMIUM INSIGHTS

• 4.1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET OVERVIEW
  • FIGURE 13 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
• 4.2 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT AND COUNTRY (2022)
  • FIGURE 14 COOLING DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
• 4.3 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.4 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: REGIONAL MIX
  • FIGURE 16 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
• 4.5 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES
  • FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 18 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising population and increasing prevalence of chronic and infectious diseases
    • 5.2.1.2 Increasing number of surgical procedures
    • 5.2.1.3 Rising number of hypothermia cases
    • 5.2.1.4 Growing number of trauma cases
    • 5.2.1.5 Rising adoption of minimally invasive cooling methods
    • 5.2.1.6 Growing demand for targeted temperature management in cardiac arrest
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Lack of awareness regarding therapeutic hypothermia systems in developing countries
    • 5.2.2.2 Availability of alternative methods
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing growth opportunities in emerging economies
    • 5.2.3.2 Developing healthcare infrastructure
    • 5.2.3.3 Growing number of contracts and agreements between market players
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Lack of skilled healthcare professionals
    • 5.2.4.2 Lack of proper supply chain management
    • 5.2.4.3 Product recalls
• 5.3 VALUE CHAIN ANALYSIS
  • FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
• 5.4 SUPPLY CHAIN ANALYSIS
  • FIGURE 20 DISTRIBUTION-STRATEGY PREFERRED BY PROMINENT COMPANIES
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 PORTER'S FIVE FORCES ANALYSIS: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
  • 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5.2 BARGAINING POWER OF SUPPLIERS
  • 5.5.3 BARGAINING POWER OF BUYERS
  • 5.5.4 THREAT OF SUBSTITUTES
  • 5.5.5 THREAT OF NEW ENTRANTS
• 5.6 REGULATORY ANALYSIS
  • TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THERAPEUTIC HYPOTHERMIA SYSTEMS
  • 5.6.1 NORTH AMERICA
    • 5.6.1.1 US
  • TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
  • FIGURE 21 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
    • 5.6.1.2 Canada
  • FIGURE 22 CANADA: APPROVAL PROCESS FOR MEDICAL DEVICES
  • 5.6.2 EUROPE
  • FIGURE 23 CE APPROVAL PROCESS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
  • 5.6.3 ASIA PACIFIC
    • 5.6.3.1 Japan
  • TABLE 6 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
    • 5.6.3.2 China
  • TABLE 7 NMPA MEDICAL DEVICES CLASSIFICATION
    • 5.6.3.3 India
• 5.7 TRADE ANALYSIS
  • 5.7.1 TRADE ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
  • TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018-2022 (USD MILLION)
• 5.8 TECHNOLOGY ANALYSIS
• 5.9 ECOSYSTEM ANALYSIS
  • FIGURE 24 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: ECOSYSTEM ANALYSIS
  • 5.9.1 ROLE IN ECOSYSTEM
  • FIGURE 25 KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS ECOSYSTEM
• 5.10 PATENT ANALYSIS
  • FIGURE 26 PATENT ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
• 5.11 KEY CONFERENCES AND EVENTS IN 2024-2025
  • TABLE 10 LIST OF CONFERENCES AND EVENTS IN 2024-2025
• 5.12 PRICING ANALYSIS
  • TABLE 11 AVERAGE SELLING PRICE OF KEY PRODUCTS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET (2019-2022)
  • TABLE 12 AVERAGE SELLING PRICE TRENDS, BY REGION, 2019-2022
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR THERAPEUTIC HYPOTHERMIA SYSTEM MANUFACTURERS
  • FIGURE 27 REVENUE SHIFT FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
  • 5.14.2 BUYING CRITERIA
  • FIGURE 29 KEY BUYING CRITERIA FOR TOP END USERS
  • TABLE 14 KEY BUYING CRITERIA, BY TOP END USER

6 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 15 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 6.2 COOLING DEVICES
  • 6.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE DEMAND
  • TABLE 16 THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 17 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 18 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 19 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 20 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.3 COOLING CATHETERS
  • 6.3.1 ABILITY TO COOL SPECIFIC AREAS EFFICIENTLY TO SUPPORT MARKET GROWTH
  • TABLE 21 THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 22 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 23 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 24 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 25 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.4 COOL CAPS
  • 6.4.1 INCREASING NUMBER OF CHEMOTHERAPY PROCEDURES TO DRIVE DEMAND
  • TABLE 26 THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 27 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 28 EUROPE: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 29 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 30 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021-2028 (USD MILLION)

7 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • TABLE 31 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 7.2 NEUROLOGY
  • 7.2.1 GROWING PREVALENCE OF TBI AND OTHER NEUROLOGICAL DISEASES TO DRIVE MARKET
  • TABLE 32 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 33 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 34 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 36 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021-2028 (USD MILLION)
• 7.3 CARDIOLOGY
  • 7.3.1 HIGH INCIDENCE OF CARDIAC ARRESTS TO SUPPORT MARKET GROWTH
  • TABLE 37 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 39 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 41 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021-2028 (USD MILLION)
• 7.4 NEONATAL CARE
  • 7.4.1 INCREASING NUMBER OF PRETERM BIRTHS TO SUPPORT MARKET GROWTH
  • TABLE 42 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 43 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 44 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 46 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021-2028 (USD MILLION)
• 7.5 OTHER APPLICATIONS
  • TABLE 47 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 48 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 49 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 51 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

8 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION

• 8.1 INTRODUCTION
  • TABLE 52 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 8.2 NORTH AMERICA
  • FIGURE 30 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT
  • 8.2.1 NORTH AMERICA: RECESSION IMPACT
  • TABLE 53 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 54 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 55 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2.2 US
    • 8.2.2.1 Growing number of cardiac arrest and brain injury cases to support market growth
  • TABLE 56 US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 57 US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 58 US: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021-2028 (THOUSAND UNITS)
  • 8.2.3 CANADA
    • 8.2.3.1 Increasing incidence of various chronic diseases to drive market
  • TABLE 59 CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 60 CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 8.3 EUROPE
  • 8.3.1 EUROPE: RECESSION IMPACT
  • TABLE 61 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 62 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 63 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.3.2 GERMANY
    • 8.3.2.1 High demand for patient cooling devices for cardiology procedures to drive market
  • TABLE 64 GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 65 GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 66 GERMANY: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021-2028 (THOUSAND UNITS)
  • 8.3.3 UK
    • 8.3.3.1 Rising number of sports injuries and accident & emergency procedures to drive market
  • TABLE 67 UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 68 UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 69 UK: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021-2028 (THOUSAND UNITS)
  • 8.3.4 FRANCE
    • 8.3.4.1 Strong healthcare system to support market growth
  • TABLE 70 FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 71 FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 72 FRANCE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021-2028 (THOUSAND UNITS)
  • 8.3.5 ITALY
    • 8.3.5.1 Growing demand for therapeutic hypothermia systems in traumatic brain injury treatment to support market growth
  • TABLE 73 ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 74 ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.3.6 SPAIN
    • 8.3.6.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market
  • TABLE 75 SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 76 SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.3.7 REST OF EUROPE
  • TABLE 77 REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 78 REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 8.4 ASIA PACIFIC
  • FIGURE 31 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT
  • 8.4.1 ASIA PACIFIC: RECESSION IMPACT
  • TABLE 79 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.4.2 CHINA
    • 8.4.2.1 Increasing disposable income of middle-class population to drive market
  • TABLE 82 CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 83 CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 84 CHINA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021-2028 (THOUSAND UNITS)
  • 8.4.3 JAPAN
    • 8.4.3.1 Rapidly increasing geriatric population to drive market
  • TABLE 85 JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 86 JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 87 JAPAN: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021-2028 (THOUSAND UNITS)
  • 8.4.4 INDIA
    • 8.4.4.1 Growing target patient population to support market growth
  • TABLE 88 INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 89 INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.4.5 REST OF ASIA PACIFIC
  • TABLE 90 REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 91 REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 8.5 REST OF THE WORLD
  • 8.5.1 REST OF THE WORLD: RECESSION IMPACT
  • TABLE 92 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 93 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 94 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.5.2 LATIN AMERICA
    • 8.5.2.1 Rising prevalence of chronic diseases to drive market
  • TABLE 95 LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 96 LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.5.3 MIDDLE EAST & AFRICA
    • 8.5.3.1 High prevalence of chronic conditions to support market growth
  • TABLE 97 MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 98 MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.5.4 GCC COUNTRIES
    • 8.5.4.1 Rise in road accident injuries and TBI to drive market
  • TABLE 99 GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 100 GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

9 COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • TABLE 101 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
• 9.3 REVENUE ANALYSIS
  • FIGURE 32 REVENUE ANALYSIS FOR KEY COMPANIES IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, 2018-2022 (USD MILLION)
• 9.4 MARKET SHARE ANALYSIS
  • FIGURE 33 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET RANKING ANALYSIS, BY KEY PLAYER (2022)
  • TABLE 102 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEGREE OF COMPETITION
• 9.5 COMPANY EVALUATION MATRIX
  • 9.5.1 STARS
  • 9.5.2 EMERGING LEADERS
  • 9.5.3 PERVASIVE PLAYERS
  • 9.5.4 PARTICIPANTS
  • FIGURE 34 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: COMPANY EVALUATION MATRIX, 2022
  • 9.5.5 COMPANY FOOTPRINT
  • TABLE 103 PRODUCT FOOTPRINT (11 PLAYERS)
  • TABLE 104 REGIONAL FOOTPRINT (11 PLAYERS)
  • TABLE 105 OVERALL COMPANY FOOTPRINT (11 PLAYERS)
• 9.6 STARTUP/SME EVALUATION MATRIX
  • 9.6.1 PROGRESSIVE COMPANIES
  • 9.6.2 STARTING BLOCKS
  • 9.6.3 RESPONSIVE COMPANIES
  • 9.6.4 DYNAMIC COMPANIES
  • FIGURE 35 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: STARTUP/SME EVALUATION MATRIX, 2022
  • 9.6.5 COMPETITIVE BENCHMARKING
  • TABLE 106 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 107 PRODUCT & SERVICE FOOTPRINT (STARTUPS/SMES)
  • TABLE 108 REGIONAL FOOTPRINT (STARTUPS/SMES)
  • TABLE 109 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)
• 9.7 COMPETITIVE SCENARIO AND TRENDS
  • 9.7.1 DEALS
  • TABLE 110 THERAPEUTIC HYPOTHERMIA SYSTEMS: DEALS, JANUARY 2020-NOVEMBER 2023
  • 9.7.2 OTHER DEVELOPMENTS
  • TABLE 111 THERAPEUTIC HYPOTHERMIA SYSTEMS: OTHER DEVELOPMENTS, JANUARY 2020-NOVEMBER 2023

10 COMPANY PROFILES

• 10.1 KEY PLAYERS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
• 10.1.1 ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
• TABLE 112 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
• FIGURE 36 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
• 10.1.2 BECTON, DICKINSON AND COMPANY
• TABLE 113 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
• FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
• 10.1.3 GENTHERM INCORPORATED
• TABLE 114 GENTHERM INCORPORATED: BUSINESS OVERVIEW
• FIGURE 38 GENTHERM INCORPORATED: COMPANY SNAPSHOT (2022)
• 10.1.4 STRYKER CORPORATION
• TABLE 115 STRYKER CORPORATION: BUSINESS OVERVIEW
• FIGURE 39 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
• 10.1.5 BELMONT MEDICAL TECHNOLOGIES
• TABLE 116 BELMONT MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
• 10.1.6 INTERNATIONAL BIOMEDICAL LTD.
• TABLE 117 INTERNATIONAL BIOMEDICAL LTD.: BUSINESS OVERVIEW
• 10.1.7 EM-MED
• TABLE 118 EM-MED: BUSINESS OVERVIEW
• 10.1.8 PHOENIX MEDICAL SYSTEMS
• TABLE 119 PHOENIX MEDICAL SYSTEMS: BUSINESS OVERVIEW
• 10.1.9 LIFE RECOVERY SYSTEMS
• TABLE 120 LIFE RECOVERY SYSTEMS: BUSINESS OVERVIEW
• 10.1.10 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
• TABLE 121 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW
• 10.1.11 MIRACRADLE (PLUSS ADVANCED TECHNOLOGIES PVT. LTD.)
• TABLE 122 MIRACRADLE: BUSINESS OVERVIEW
• 10.2 OTHER PLAYERS
  • 10.2.1 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
  • TABLE 123 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY OVERVIEW
  • 10.2.2 PFM MEDICAL HICO GMBH
  • TABLE 124 PFM MEDICAL HICO GMBH: COMPANY OVERVIEW
  • 10.2.3 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.
  • TABLE 125 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.: COMPANY OVERVIEW
  • 10.2.4 ASPEN SYSTEMS
  • TABLE 126 ASPEN SYSTEMS: COMPANY OVERVIEW
  • 10.2.5 COOLTECH MEDICAL
  • TABLE 127 COOLTECH MEDICAL: COMPANY OVERVIEW
  • 10.2.6 GLOBAL HEALTHCARE SG
  • TABLE 128 GLOBAL HEALTHCARE SG: COMPANY OVERVIEW
  • 10.2.7 CRYOTHERMIC SYSTEMS INCORPORATED
  • TABLE 129 CRYOTHERMIC SYSTEMS INCORPORATED: COMPANY OVERVIEW
  • 10.2.8 PAXMAN COOLERS LTD.
  • TABLE 130 PAXMAN COOLERS LTD.: COMPANY OVERVIEW
  • 10.2.9 DIGNITANA AB
  • TABLE 131 DIGNITANA AB: COMPANY OVERVIEW
  • 10.2.10 WISHCAPS
  • TABLE 132 WISHCAPS: COMPANY OVERVIEW
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

11 APPENDIX

• 11.1 DISCUSSION GUIDE
• 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 11.3 CUSTOMIZATION OPTIONS
• 11.4 RELATED REPORTS
• 11.5 AUTHOR DETAILS

관련자료